Eagle Asset Management Inc
- SEC CIK
- 0000790502
- Latest filing
- Nov 12, 2024
APLS holding history
Apellis Pharmaceuticals, Inc. in every 13F filed by Eagle Asset Management Inc, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
APLS overviewAll 13F holders of APLSFull Q3 2024 holdings
- Shares (Q3 2024)
- 0
- Sold out in Q3 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 8
- Since Q3 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2024 | 0 | $0 | 0.0% | −802,253−100.0% | Sold out | Holders |
| Q2 2024 | 802,253 | $29.1M | 0.2% | −43,280−5.1% | Reduced | Holders |
| Q1 2024 | 845,533 | $50.5M | 0.3% | +399,533+89.6% | Added | Holders |
| Q4 2023 | 446,000 | $26.7M | 0.1% | −3,970−0.9% | Reduced | Holders |
| Q3 2023 | 449,970 | $17.1M | 0.1% | −962−0.2% | Reduced | Holders |
| Q2 2023 | 450,932 | $41.1M | 0.2% | +221,550+96.6% | Added | Holders |
| Q1 2023 | 229,382 | $15.1M | 0.1% | +93,268+68.5% | Added | Holders |
| Q4 2022 | 136,114 | $6.84M | <0.1% | −5,103−3.6% | Reduced | Holders |
| Q3 2022 | 141,217 | $9.64M | 0.1% | +141,217 | New | Holders |